Rugby Player-Turned-Researcher Seeks Mechanisms Behind Prostate Cancer Metastases

Leigh Ellis, PhD, once seemed destined for a career intercepting passes as a professional rugby player. Now, the Dana-Farber researcher is devising plays to intercept prostate cancer cells before they become metastatic. These tactics could also potentially slow other genitourinary diseases, including kidney cancer. Ellis’ laboratory works to better understand the underlying genetic and epigenetic … Read more

After 80 Years, Genetic Causes of Diamond-Blackfan Anemia Come Into View

This post was originally published on Vector, Boston Children Hospital’s science and clinical innovation blog. In 1938, Louis K. Diamond, MD, and Kenneth Blackfan, MD, at Boston Children’s Hospital described a severe congenital anemia that they termed “hypoplastic” (literally, “underdeveloped”) because of the bone marrow’s inability to produce mature, functioning red blood cells. Eighty years … Read more

Trials Open New Avenues of Endometrial Cancer Treatment

A new generation of drugs and drug combinations is changing the outlook for patients with endometrial cancer. The results of the first clinical trials of the new therapies were so promising that they’ve led researchers to launch follow-up trials to explore the potential for even better outcomes.  The trials are geared to patients diagnosed with … Read more

What You Should Know About Alcohol Consumption and Personal Health

The link between alcohol consumption and personal health has long been a controversial subject. For several decades, research has found conflicting evidence regarding alcohol’s physical effects—often resulting in ever-changing headlines and diet trends. Stacy Kennedy, MPH, RD, a senior clinical nutritionist at Dana-Farber Cancer Institute, discusses the risks and benefits often associated with alcohol.    … Read more

Study Resolves Decades-Long Mystery About the Most Commonly Mutated Gene in Cancer

The most commonly mutated gene in cancer has tantalized scientists for decades with the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency at a handful of points dubbed “hot spots.” Does this imbalance suggest that hotspot mutations are especially conducive to … Read more